315 Results for: "Charles River Laboratories Cell Solutions"

Supplier: Charles River Laboratories Cell Solutions

CD34⁺ cells are isolated using positive immunomagnetic cell separation procedures from umbilical cord blood. Human cord blood is collected aseptically at the time of delivery from healthy pregnant women under institutional review board (IRB) approved procedures.

Supplier: Charles River Laboratories Cell Solutions

Human peripheral blood M2 macrophages are derived from purified monocytes. CD14⁺ monocytes were positively selected via immunomagnetic beads and were cultured in the presence of M-CSF for 10 days. The M2 phenotyping was confirmed by morphology and the expression of specific biomarkers which monitored by flow cytometry. The cells were harvested after 10 days of in vitro culture.

Supplier: Charles River Laboratories Cell Solutions

Human mononuclear cells, multiple myeloma

Supplier: Charles River Laboratories Cell Solutions

Human serum, chronic lymphocytic leukemia (CLL)

Supplier: Charles River Laboratories Cell Solutions

Mesenchymal stem cells (MSC) are cultured from freshly collected adult human bone marrow. MSCs are isolated by adherence from bone marrow mononuclear cells, isolated using a density gradient. Adherent cells were cultured in MEM-alpha, supplemented with L-glutamine and Human Platelet Lysate. Bone marrow aspirate is collected from healthy human volunteer donors under IRB approved informed consent and drawn from the posterior iliac crest using a syringe containing anticoagulant.

Supplier: Charles River Laboratories Cell Solutions

Ulcerative colitis (UC) is isolated from mononuclear cells collected from IRB-consented donors diagnosed with ulcerative colitis (UC).

Supplier: Charles River Laboratories Cell Solutions

Bone marrow is a major source of stem cells, which are being used in cancer research, cell studies, transplantation studies, and other research.

Supplier: Charles River Laboratories Cell Solutions

CD34 depleted mononuclear cells from mobilised peripheral blood are isolated by depleting the CD34 cells using immunomagnetic anti-CD34 microbeads.

Supplier: Charles River Laboratories Cell Solutions

CD34⁺ cells are isolated using positive immunomagnetic cell separation procedures from bone marrow. Bone marrow aspirates and cells, drawn from the posterior iliac crest using a syringe containing anticoagulant, are collected from normal human volunteers using institutional review board (IRB) approved procedures.

Supplier: Charles River Laboratories Cell Solutions

Human serum used for researching the causes, diagnosis, supportive care and treatment of multiple sclerosis (MS). Collected from IRB-consented donors diagnosed with MS.

Supplier: Charles River Laboratories Cell Solutions

Human plasma, breast cancer (BC)

Supplier: Charles River Laboratories Cell Solutions

Plasma used for researching the causes, diagnosis, supportive care and treatment of ulcerative colitis (UC). Collected from IRB-consented volunteer donors diagnosed with UC.

Supplier: Charles River Laboratories Cell Solutions

Human serum, lung cancer

Supplier: Charles River Laboratories Cell Solutions

Human peripheral blood plasma used for researching the causes, diagnosis, supportive care and treatment of chronic myeloid leukemia (CML). Collected from IRB consented chronic myeloid leukemia (CML) disease donors.

Supplier: Charles River Laboratories Cell Solutions

Dendritic cells are obtained from a leukapheresis product using immunomagnetic separation techniques.

Supplier: Charles River Laboratories Cell Solutions

Mononuclear cells (MNCs) used for researching the causes, diagnosis, supportive care and treatment of Hepatitis C Virus (HCV). Human mononuclear cells are collected from human volunteer donors diagnosed with Hepatitis C virus under IRB approved informed consent.

Supplier: Charles River Laboratories Cell Solutions

ANTI-MART-1 (26-35) CD8+ T CELLS, 1 TO 2 MILLION CELLS/VIAL, CRYOPRESERVED 1 * 2 Mou

Supplier: Charles River Laboratories Cell Solutions

CD8+ T CELLS, NEGATIVE SELECTION, 5 TO 10 MILLION CELLS, CRYOPRESERVED 1 * 10 Mou

Supplier: Charles River Laboratories Cell Solutions

NAIVE CD4+ T CELLS, 5 TO 10 MILLION CELLS, CRYOPRESERVED 1 * 10 Mou

Supplier: Charles River Laboratories Cell Solutions

PBMC PELLET, 50 TO 100 MILLION CELLS, CRYOPRESERVED 1 * 100 Mou

Supplier: Charles River Laboratories Cell Solutions

TYPE 1 DIABETES (T1-D), HUMAN PBMC, 20 TO 50 MILLION CELLS, CRYOPRESERVED 1 * 20 Mou

Supplier: Charles River Laboratories Cell Solutions

C57BL/6 SPLEEN CELLS, 5 TO 10 MILLION CELLS, CRYOPRESERVED 1 * 10 Mou

Supplier: Charles River Laboratories Cell Solutions

C57BL/6 MACROPHAGES, 5 TO 10 MILLION CELLS, CRYOPRESERVED 1 * 10 Mou

Supplier: Charles River Laboratories Cell Solutions

BALB/C DENDRITIC CELLS, 5 TO 10 MILLION CELLS, CRYOPRESERVED 1 * 10 Mou

Supplier: Charles River Laboratories Cell Solutions

LEUKOPAK - FIVEPAK 5 SOLOPAKS (10 TO 12.5 BILLION CELLS), CRYOPRESERVED 1 * 1 items

Supplier: Charles River Laboratories Cell Solutions

PLASMA - SICKLE CELL DISEASE (SCD), 2ML, CRYOPRESERVED 1 * 2 mL

Supplier: Charles River Laboratories Cell Solutions

Mobilized Peripheral Blood CD34+ Stem Cells G-CSF & Mozobil, Cryo - 1 x 10e6 cells 1 * 1 Mou

Supplier: Charles River Laboratories Cell Solutions

Human cord blood plasma is obtained by centrifugation of the cord blood. Cord blood is collected aseptically at the time of delivery from healthy pregnant women under IRB approved informed consent and tested negative for evidence of transmissible in 1 * 10 ml

Supplier: Charles River Laboratories Cell Solutions

Human cord blood CD56+ NK cells are isolated from cord blood MNCs using immunomagnetic cell separation procedures. Cord blood is col lected aseptically at the time of delivery from healthy pregnant women under IRB approved informed consent and tested 1 * 1 Mou

Supplier: Charles River Laboratories Cell Solutions

A leukopak is an enriched leukapheresis product collected from normal peripheral blood (PB). A leukopak contains 85% mononuclear ce lls. PB is collected from healthy volunteer donors under IRB approved informed consent by leukapheresis and tested ne 1 * 1 PAC